Risperdal

Approved Uses

Risperdal is primarily prescribed to treat symptoms of several psychiatric conditions. It belongs to a class of drugs known as atypical antipsychotics, which work by helping to restore the balance of certain natural substances in the brain.

Schizophrenia

Risperdal is used for the treatment of schizophrenia in adults and children who are at least 13 years old. It helps manage symptoms such as hallucinations, delusions, and disordered thinking.

Bipolar Disorder

This medication is used to treat manic or mixed episodes associated with bipolar I disorder. It may be used alone or in combination with other medications, such as lithium or valproate. For this condition, it is approved for use in adults and children 10 years of age and older.

Irritability in Autistic Disorder

Risperdal is used to treat irritability associated with autistic disorder in children and adolescents between the ages of 5 and 16. This includes symptoms such as:

• Aggression toward others
• Deliberate self-injury
• Temper tantrums
• Quickly changing moods

Mechanism of Action

Risperdal belongs to a class of medications known as atypical antipsychotics. It works by changing the activity of certain natural substances in the brain, primarily dopamine and serotonin.

These chemicals, called neurotransmitters, help send signals between nerve cells. In conditions like schizophrenia or bipolar disorder, it is believed that an imbalance of these chemicals can lead to symptoms such as hallucinations, delusions, or extreme mood swings.

By blocking specific receptors for dopamine and serotonin, Risperdal helps to restore a more normal balance. This can help improve:

• Thinking and concentration
• Mood stability
• Behavioral control

While the exact way the medication works is not fully understood, its effect on these brain chemicals is the primary way it helps control symptoms.

Common Side Effects

Many people taking Risperdal experience mild side effects. These may include:

• Drowsiness, tiredness, or fatigue
• Dizziness or lightheadedness
• Nausea, vomiting, or stomach pain
• Constipation or diarrhea
• Increased appetite and weight gain
• Dry mouth or increased saliva production
• Restlessness, anxiety, or agitation
• Difficulty falling or staying asleep
• Muscle or joint pain

Serious Side Effects

Some side effects can be serious. Contact a healthcare provider immediately if you experience:

• Uncontrolled movements of the face, tongue, or limbs
• Severe muscle stiffness, high fever, sweating, confusion, or irregular heartbeat
• Seizures
• Difficulty swallowing or breathing
• Signs of high blood sugar, such as increased thirst, frequent urination, or extreme hunger
• A painful erection that lasts for several hours
• Fainting or vision changes
• Rash, hives, or swelling of the face, throat, or tongue

Risperdal may also cause changes in hormone levels, which can lead to breast enlargement or discharge and changes in menstrual cycles.

Boxed Warning: Dementia-Related Psychosis

Elderly patients with dementia-related psychosis who are treated with antipsychotic drugs like Risperdal face an increased risk of death. Risperdal is not FDA-approved for the treatment of patients with dementia-related psychosis.

Cerebrovascular Adverse Events

In clinical trials of elderly patients with dementia, there was a higher incidence of stroke and transient ischemic attacks (mini-strokes), some of which resulted in death.

Neuroleptic Malignant Syndrome (NMS)

NMS is a rare but potentially fatal condition associated with antipsychotic medication. Symptoms may include high fever, muscle stiffness, altered mental status, and evidence of autonomic instability, such as irregular pulse or blood pressure.

Tardive Dyskinesia

This condition involves involuntary, repetitive body movements, such as grimacing, tongue movements, or rapid eye blinking. It can become permanent even after the medication is discontinued. The risk is believed to increase with the duration of treatment and the total cumulative dose.

Metabolic Changes

Risperdal can cause significant metabolic changes, which may include:

• Hyperglycemia and Diabetes: High blood sugar, sometimes extreme and associated with ketoacidosis or coma, has been reported. Patients with a diagnosis of diabetes or risk factors for diabetes should be monitored regularly.
• Dyslipidemia: Changes in cholesterol and triglyceride levels may occur.
• Weight Gain: Significant weight gain has been observed in patients taking Risperdal and should be monitored during treatment.

Hyperprolactinemia

Risperdal can elevate levels of the hormone prolactin. Long-term elevation may lead to side effects such as breast enlargement (gynecomastia), milk secretion (galactorrhea), or menstrual irregularities.

Other Important Precautions

• Orthostatic Hypotension: Risperdal may cause a sudden drop in blood pressure when standing up, leading to dizziness or fainting, especially during the initial dose titration period.
• Low White Blood Cell Count: Some patients may experience a dangerous drop in white blood cell counts (leukopenia, neutropenia, or agranulocytosis). Monitoring may be required for those with a history of low counts.
• Seizures: Caution is advised for individuals with a history of seizures or conditions that lower the seizure threshold.
• Cognitive and Motor Impairment: The medication may cause drowsiness and impair judgment or motor skills. Caution should be used when operating heavy machinery or driving.
• Body Temperature Regulation: Antipsychotics can disrupt the body's ability to reduce core temperature. Caution is advised when engaging in strenuous exercise or being exposed to extreme heat.
• Priapism: Rare cases of painful, long-lasting erections have been reported and require immediate medical intervention.
• Dysphagia: Antipsychotic use has been linked to difficulty swallowing, which may increase the risk of aspiration pneumonia.

Pregnancy

Taking Risperdal during the third trimester of pregnancy may cause complications in the newborn after delivery. These issues are generally categorized as extrapyramidal symptoms (movement disorders) or withdrawal symptoms. Healthcare providers monitor for several signs in infants exposed to the drug late in pregnancy, including:

• Agitation or irritability
• Tremors or shaking
• Unusually stiff or limp muscles (hypertonia or hypotonia)
• Excessive sleepiness
• Difficulty breathing
• Feeding problems

If you are pregnant or planning to become pregnant, discuss the risks and benefits of treatment with your doctor. It is important not to stop taking the medication abruptly without medical guidance, as untreated mental health conditions can also carry risks. There is a pregnancy exposure registry available to monitor the health of individuals and their babies when antipsychotic medications are used during pregnancy.

Breastfeeding

Risperdal and its active metabolites pass into breast milk. Because of the potential for side effects in the nursing infant, a decision must be made whether to discontinue breastfeeding or discontinue the drug. This decision typically takes into account the importance of the medication to the mother's health and the potential risks to the infant. Consult with a healthcare provider to determine the safest course of action for your specific situation.

Oral Forms

• Tablets: Standard tablets taken by mouth.
• Orally Disintegrating Tablets: These tablets are designed to dissolve quickly on the tongue and can be swallowed with or without water.
• Oral Solution: A liquid form of the medication that can be taken directly or mixed with specific compatible beverages.

Injectable Forms

• Long-Acting Intramuscular Injection: This form is administered by a healthcare professional into the muscle. It is typically provided as a kit containing a vial of powder and a prefilled syringe of liquid used to mix the medication before injection.

FDA Approval and Indications

Risperdal (risperidone) is an atypical antipsychotic medication approved by the U.S. Food and Drug Administration (FDA). It is indicated for the treatment of schizophrenia in adults and pediatric patients ages 13 to 17. It is also approved for the treatment of manic or mixed episodes associated with bipolar I disorder in adults and pediatric patients ages 10 to 17, and for the treatment of irritability associated with autistic disorder in children and adolescents ages 5 to 16.

Boxed Warning

Increased Mortality in Elderly Patients with Dementia-Related Psychosis: The FDA has issued a boxed warning for Risperdal. Elderly patients with dementia-related psychosis treated with antipsychotic drugs are at an increased risk of death. Risperdal is not approved for the treatment of patients with dementia-related psychosis.

Regulatory Safety Communications

The FDA monitors and regulates safety information for Risperdal, which includes warnings for several serious conditions:

• Cerebrovascular Adverse Events: Increased risk of stroke and other cerebrovascular events in elderly patients with dementia.
• Neuroleptic Malignant Syndrome (NMS): A rare but potentially fatal reaction to antipsychotic medications.
• Tardive Dyskinesia: A condition involving involuntary, repetitive body movements.
• Metabolic Changes: Risks of high blood sugar (hyperglycemia), high cholesterol, and weight gain.
• Hyperprolactinemia: Elevations in prolactin levels, which may lead to hormonal imbalances.

Managing Discontinuation

It is important to follow your doctor's instructions when stopping Risperdal. Stopping the medication suddenly may cause your condition to worsen or lead to a return of psychiatric symptoms. Your healthcare provider will likely create a schedule to decrease your dose gradually before stopping it completely.

If you are using the long-acting injection form of risperidone, the medication stays in your system for several weeks after the last dose. Even with this form, you should discuss the discontinuation process with your medical team to monitor for any changes in your condition.

Always seek medical advice before making any changes to how you take your medication. If you miss doses or stop taking the drug, your original symptoms may return quickly.